Cargando…
Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients
BACKGROUND: Guideline-based best practice treatment for muscle invasive bladder cancer (MIBC) involves neoadjuvant chemotherapy followed by radical cystectomy (NACRC). Prior studies have shown that a minority of patients receive NACRC and older age and renal function are drivers of non-receipt of NA...
Autores principales: | Au, Daniel, Lee, Eugene K., Popoola, Taiye O., Parker, William P., Onge, Jarron M. Saint, Ellis, Shellie D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Urologia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321501/ https://www.ncbi.nlm.nih.gov/pubmed/33848073 http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.0594 |
Ejemplares similares
-
Editorial Comment: Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients
por: Korkes, Fernando
Publicado: (2021) -
Direct primary care: Family physician perceptions of a growing model
por: Brekke, Gayle, et al.
Publicado: (2021) -
An electronic application for rapidly calculating Charlson comorbidity score
por: Hall, William H, et al.
Publicado: (2004) -
Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
por: Ludvigsson, Jonas F, et al.
Publicado: (2021) -
Analysis of the Impact of Comorbidities on Endometrial Lesions Using the Charlson Comorbidity Index in Western Romania
por: Furau, Alexandru, et al.
Publicado: (2021)